Synthesis and Antimicrobial Screening of Metal-ligand Complexes Derivative from (2-chloroquinolin-3-yl)methylene)hydrazine) and their Biological Studies
1Department of Chemistry, Deogiri College, Chhatrapati Sambhajinagar, MS, India
2Department of Chemistry, Radhabai Kale Mahila Mahavidyalaya Ahmednagar, MS, India.
Corresponding Author E-mail: s_bembalkar@yahoo.com
DOI : http://dx.doi.org/10.13005/ojc/410305
ABSTRACT:This study presents the synthesis of a Schiff base ligand, 1,2-bis((2-chloroquinolin-3-yl)methylene)hydrazine, via a condensation reaction between an amine and a carbonyl compound. The resulting ligand was subsequently utilized to synthesize Cu(II), Co(II), and Ni(II) complexes. Characterization of the ligand was performed using analytical techniques such as ¹H NMR, FTIR, and mass spectrometry. Further structural analysis of the metal complexes was conducted through spectroscopic methods, including FTIR and UV. Their antifungal activity was assessed in vitro, revealing that the Ni(II) complex exhibited the highest efficacy against the tested fungal strains. Additionally, the Zn(II) complex demonstrated notable antifungal properties, with activity ranging from 14–35 µg/mL against Candida albicans, Candida glabrata, Aspergillus flavus, and Cryptococcus neoformans. The antibacterial potential of the complexes was also evaluated in vitro against three distinct bacterial strains. Compounds 6b and 6h displayed comparable potency to the reference drug Ampicillin against Escherichia coli, with IC50 values of 46 µg/mL. Furthermore, compound 6h exhibited similar activity to Ampicillin against Bacillus subtilis, with an IC50 value of 50 µg/mL.
KEYWORDS:Antibacterial; Antifungal activity; Bis hydrazine; Metal complexes
Introduction
The chemistry of transition metal complexes has garnered significant interest due to their catalytic and bioinorganic properties. These complexes are also noteworthy for their potential biological activities, including anticancer1, antimicrobial2, antimalarial3, and antitumor4. antibacterial5, antiviral6, antinflammatory7, antioxidant8. Schiff base compounds, which are formed through thecompression of prime amines by carbonyl compounds (aldehydes) and the elimination of water molecules, are particularly important in this context. The formation of Schiff bases is often facilitated by the presence of a dehydrating agent (Scheme 1).
The choice of metal integrated into the complex and the particular Schiff base utilized have a substantial impression on their biological activity. Metal-Schiff base compounds demonstrate more potent drug action mechanisms than their decently organic counterparts. Owing to the biologically active azomethine group, Schiff bases serve as highly effective ligands for metal compounds. This azomethine structure, with its electron-deficient carbon and electron-rich nitrogen, facilitates diverse electrophilic and nucleophilic reactions at these specific sites9-11.
Schiff bases that coordinate with oxygen, nitrogen, and other similar donor atoms, and their complexes, have been extensively studied and statedto exhibit a comprehensivevarietyof biological activities, with activity beside bacteria, fungi, and certain types of tumors. These compounds possess numerous biochemical, clinical, and pharmacological properties12. The synthesis of the metal complexes followed procedures reported in the literature13,14.
The chemistry of Schiff bases represents a significant area of study within coordination chemistrybecause of their capacity to form stable multiplexes with various metal ions, leading to applications across multiple disciplines. A notable focus in this field has been theusageofSchiff-base ligands to progressphenoxo-bridged binuclearmultiplexesby eitherhomometalliccenters. These Schiff-base complexes are crucial in biomedical, biomimetic, and catalyticorganizationsand also support liquid crystalline phases15-22. Schiff bases synthesized from aliphatic aldehydes tend to be more unstable and prone to polymerization compared to those derived from aromatic aldehydes, which exhibit greater stability due to more effective conjugation. Aldehydes, which are less sterically hindered and more electrophilic than ketones, react more readily, facilitating the formation of Schiff bases. The simplicity of synthesis and the ready availability of Schiff bases have made them a subject of considerable interest. The development of several applications in the fields of inorganic23, bioinorganic24, organic synthesis25, environmental26, and coordination chemistry27 are the significant interest.
Materials and Methods
All the procured substances used were methodical mark, distilled solvents were used.
Metal salts were used without further refinement.
![]() |
Scheme 1: Synthesis of hydrazine derivative.Click here to View Scheme |
In 50 ml round bottom flask to stirred solution of compound (1) (1mmol) in ethanol (10 mL) was treated by hydrazine hydrate (2) (6 mmol) and 1-2 drops of rigorous sulphuric acid at room temperature. The reaction mixture was refluxed in a preheated oil bath for four hours, resulting in the formation of 2-chloro-3-(hydrazonomethyl)quinolone (3). Subsequently, an extra 1 mmol of 2-chloroquinolin-3-carbaldehyde (4) and 1–2 drops of concentrated H₂SO₄ were introduced, and the mixture was further refluxed for another four hours. Upon conclusion of the reaction, as observed by T. L.C. by means of an ethyl acetate: n-hexane (3:7) system, the solvent was evaporated. The resulting crude product was precipitated by adding ice, followed by filtration, drying, and recrystallization from ethanol.The isolated yellow solid was confirmed by NMR and Mass spectroscopic analysis. IR (KBrcm-1): 3402 (OH), 3011 (Ar-H), 1668 (Imine C=N), 1579 (C=C), 1170 (C-O-C).
Preparation procedure
![]() |
Scheme 2: Preparation procedureClick here to View Scheme |
The metal salts (1mmol) were addition the ethyl alcohol solution of the ligand (5) (2 mmol). A some what basic pH of the reaction was carried out in slightly basic condition by adding 1 mmol of ammonia, and then this contentswere refluxedup to 5 to 6 hrs. The development of the reaction was checked by using T.L.C. and also monitored the colour changes. The subsequent yield was poured on petri dish and cool, filtration and dehydrated (6a-h). Each product was recrystallized from ethanol andthen take out its melting point, confirmed by IR and UV spectroscopy. Physical data of synthesized compounds are shows in table 1.
Table 1: Physical information of manufactured complexes
| Entry | Sample code | Ligand/metal salt | Elemental analysis (%) | ||||
| C | H | N | M | Cl | |||
| 1 | 5 | Ligand | 63.32 | 3.17 | 14.77 | 0 | 18.73 |
| 2 | 6a | CdL4 | 55.14 | 2.76 | 12.87 | 12.91 | 16.31 |
| 3 | 6b | CoL4 | 58.75 | 2.94 | 13.71 | 7.21 | 17.38 |
| 4 | 6c | CuL4 | 58.43 | 2.92 | 13.63 | 7.73 | 17.28 |
| 5 | 6d | NiL4 | 58.77 | 2.93 | 13.71 | 7.18 | 17.39 |
| 6 | 6e | FeL4 | 58.98 | 2.94 | 13.76 | 6.86 | 17.45 |
| 7 | 6f | SrL4 | 56.76 | 2.83 | 13.24 | 10.36 | 16.79 |
| 8 | 6g | ZnL4 | 58.29 | 2.91 | 13.60 | 7.94 | 17.24 |
| 9 | 6h | ZrL4 | 56.52 | 2.82 | 13.19 | 10.74 | 16.72 |
Spectroscopic data of Synthesized metal Complexes
The N-H stretching band of the free ligand exhibited a shift towards lower frequencies in the spectra of all complexes, suggesting the involvement of the N-H group in complex formation. The infrared spectral data (ν, cm-1) for C=N, M-N, and C-H bonds in the metal complexes is provided.
The (6a) complex have Lemon yellow colour solid with melting point 274°C infrared Spectral values (cm-1) 1672 (C=N), 639 (M-N), 3068 (C-H), 3268 (O-H), UV spectra of the (6a) metal complex werenotedin ethanol solvents λmaxvalue is 344.99 nm.
(6b) Complex have grey colour solid with melting point >3000C Infrared Spectral values (cm-1) 1611 (C=N) 687(M-N), 3071(C-H), 3486 (O-H), UV Spectra of the (6b) metal complex were noted in ethanol solvents λmaxvalue is 201.58 nm.
(6c) Complex have yellowish brown colour solid with melting point 2800C Infrared Spectral values (cm-1)1611 (C=N), 687 (M-N), 3072 (C-H), 3407 (O-H), UV spectra of the (6c) metal complex were noted in ethanol solvents λmaxvalue is 385.53 nm.
(6d) Complex have brown colour solid with melting point 2980C Infrared Spectral values (cm-1)1580 (C=N), 689 (M-N), 3055 (C-H), 3180 (O-H), UV spectra of the (6d) metal complex were noted in ethanol solvents λmaxvalue is nm.
(6e) Complex have yellow colour solid with melting point >3000C Infrared Spectral values (cm-1) 1581 (C=N), 646 (M-N), 3060 (C-H), 3133 (O-H), UV spectra of the (6e) metal complex were noted in ethanol solvents λmaxvalue is 383.28 nm.
(6f) Complex have white colour solid with melting point >3000C Infrared Spectral values 1610 (C=N), 688 (M-N), 3069 (C-H), 3389 (O-H), UV spectra of the (6f) metal complex were noted in ethanol solvents λmaxvalue is 350.06 nm.
(6g) Complex have yellowish green colour solid with melting point 2700C Infrared Spectral values cm-1611 (C=N), 689 (M-N), 3070 (C-H), 3497 (O-H), UV spectra of the (6g) metal complex were noted in ethanol solvents λmaxvalue is 203.6 nm.
(6h) Complex have lightYellow colour solid with melting point 2860C Infrared Spectral values 1596 (C=N), 686 (M-N) 3065 (C-H), 3429 cm-1 (O-H). UV spectra of the (6h) metal complex were noted in ethanol solvents λmaxvalue is 343.06 nm.
Result and Discussion
Antifungal activity (in vitro)
The newly manufacturedcomplexes were evaluated for theirin vitroAntifungal activity in contradiction ofnumerous fungal pathogens. MICstandards were resoluteby means of the normal agar technique, with Miconazolehelping as the reference drug. Dimethyl sulfoxide was used as the solvent control. TheMIC values (µg/mL) for the tested compounds and Miconazole are presented in Table 2. According to the data in Table 1, all synthesized compounds demonstrated decentto reasonableantifungalefficacy in contradiction of the examined fungal strains.
Table 2: Antifungal activity of complexes
| Complexes | MICa µg/mL | ||||
| C.albicans | C.glabrata | A. fumigates | A. flavus | C.neoformans | |
| 6a | 51 | 50 | 57 | 37 | 39 |
| 6b | 25 | 28 | 38 | 15 | 16 |
| 6c | 26 | 29 | 38 | 18 | 15 |
| 6d | 28 | 32 | 44 | 20 | 20 |
| 6e | 22 | 24 | 32 | 11 | 10 |
| 6f | 30 | 32 | 41 | 22 | 25 |
| 6g | 35 | 36 | 40 | 18 | 24 |
| 6h | 25 | 24 | 35 | 14 | 14 |
| Miconazole | 25 | 25 | 35 | 12 | 12 |
a Values are theordinaryof threeevaluations
The results revealed that the entire Schiff base metal complex complexesexhibition antifungal activity. The compounds with the decent antifungal outlineswere 6b, 6e, and 6h, each awarding at slightestone MIC value reachingbetween10-40 µg mL-1. Table 1 results observations show that the Schiff base metal complex compounds are more active than their respective Schiff base. The Ni complex i.e. 6ewas found to be highly active towards all the selected fungi strains. A good effectiveness is exhibited by Zn complex i.e. 6h, which acts in the range 14–35 µg mL-1 toward C. albicans, C.glabrata, A. fumigates, A. flavusand Cryptococcus neoformans.
Antibacterial activity (in vitro)
The antibacterial properties of the newly manufacturedcomplexeswere assessed in vitro against three distinct bacterial strains. MIC standards were measured by means of the normal agar process, with Ampicillin serving as the reference drug and DMSO as the solvent control. The results, as shown in Table 3, indicate that the synthesized compounds exhibited moderate to strong antibacterial effects in contradiction ofE. coli, B. subtilis, and S. aureus.
Table 3: Antibacterial activity (in vitro) data
| Compounds | MICa µg/mL | ||
| E. coli | B. subtilis | S. aureus | |
| 6a | >100 | >100 | >100 |
| 6b | 46 | 48 | 48 |
| 6c | 50 | 50 | 50 |
| 6d | 56 | 60 | 52 |
| 6e | 62 | 55 | 60 |
| 6f | 70 | 70 | 72 |
| 6g | 60 | 55 | 60 |
| 6h | 48 | 50 | 52 |
| Ampicillin | 50 | 50 | 48 |
a Values are the ordinary of three evaluations
The consequences ofAntibacterial activity (in vitro) as obtainablein Table 3,indicate that the manufacturedcomplexes6b and 6hwereoriginateto beadditional equipotent to that oftypical drug Ampicillin against Escherichia coli IC50values 46 µg/mL and 48 µg/mL correspondingly. The synthesized complexes 6hwerefound to be equipotent to that of standard drug Ampicillin against Bacillus subtilis IC50value 50 µg/mL. It was also noticed that the derivatives with the “Zn” and “Cd” metal in their structure were found to be potent compounds among the other synthesized derivatives.
Conclusion
In conclusion, a new ligand was synthesized using aldehydes, vanillin and 2-chloro-3-carbaldehyde,along with amine hydrazine hydrate. This ligand was further utilized for the synthesis of metal-ligand complexes. The anewmanufactured ligand and metal complexes were categorizedby means of various spectroscopic methods, including 1H NMR, Mass spectrometry, IR spectroscopy, UV spectroscopy, and antibacterial and antifungal activity assays. The monodentate Schiff base substituted hydrazineLigand and its metal developments were positivelymanufactured and categorized using the aforementioned spectroscopic techniques. The antifungal and antibacterial activities of themanufactured metal complexes were evaluated, revealing that the compound Ni exhibited significantly good in vitroantifungal activity against C.albicans, C.glabrata, A.fumigatus, A.flavus, and C.neoformans. Complexes with Cd and Zn demonstrated in vitroantifungal activity when compared to the standard drug Miconazole against the fungiform strains C.albicansand C. glabrata.
Acknowledgement
The authors extend their heartfelt appreciation to the Principal and Head of the Chemistry Department, Deogiri College, ChhatrapatiSambhajinagar, Maharashtra, India, for generously providing access to the laboratory facilities essential for conducting this research. This article does not involve any studies conducted with human or animal participants by any of the authors.
Funding Sources
There is no any funding for this research
Conflict of Interest
We announced no conflicts of interests.
References
- Afrasiabi Z.; Sinn E.; Padhye S.; Dutta S.; Padhye S.; Newton C.; Anson C. E.; Powell A. K., Transition metal complexes of phenanthrenequinonethiosemicarbazone as potential anticancer agents: synthesis, structure, spectroscopy, electrochemistry and in vitro anticancer activity against human breast cancer cell-line, T47D. Journal of Inorganic Biochemistry., 2003, 95(4), 306-314.
CrossRef - Abd El-Halim, H.F.; Mohamed, G.G; Anwar, M.N., Antimicrobial and anticancer activities of Schiff base ligand and its transition metal mixed ligand complexes with heterocyclic base, Applied Organometallic Chemistry., 2018, 32:e3899
CrossRef - Aggarwal S.; Paliwal D.; Kaushik D.; Gupta GK.; Kumar A.,Pyrazole Schiff Base Hybrids as Anti-Malarial Agents: Synthesis, In Vitro Screening and Computational Study. Comb Chem High Throughput Screen.,2018, 21(3),194-203.
CrossRef - A.; Al-HakimiA.N.; El-Sayed SaeedS.; Alhamzi E.H.L.; Albadri A.E.A.E., Synthesis, characterization, and anticancer activity of some metal complexes with a new Schiff base ligand, Arabian Journal of Chemistry.,2022, 15 (2),103559.
CrossRef - Jarrahpour A.; Khalili D.; De Clercq E.; Salmi C.; Brunel J.M., Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives, Molecules., 2007, 12 (8), 1720–1730.
CrossRef - Sonmez F.; Gunesli Z.; Kurt B.Z.; Gazioglu I.; Avci D.; Kucukislamoglu M., Synthesis, antioxidant activity and SAR study of novel spiro-isatin-based Schiff bases, Molecular Diversity.,2019, 23 (4), 829–844.
CrossRef - Timofeeva D.S; Ofial A.R.; Mayr H., Nucleophilic reactivities of Schiff base derivatives of amino acids, Tetrahedron, 2019, 75, 459–463.
CrossRef - Xia M.; Wang S.H.; Yuan W.B., Lewis acid catalyzed electrophilic substitution of indole with aldehydes and Schiff bases under microwave solvent-free irradiation, Synthetic Communication., 2004, 34, 3175–3182.
CrossRef - Wantulok J.; Szala M.; Quinto A.; Nycz J.E.; Giannarelli S.; SokolovaR.; Ksiązek J. Kusz, M.,Synthesis, electrochemical and spectroscopic characterization of selected quinolinecarbaldehydes and their Schiff base derivatives, Molecules., 2020, 25 , 2053–2073.
CrossRef - ; PurohitS.; Oswal P.; Rawat S.; NegiV.; Singh A.K.; Kumar A.; Nucleophilic substitution reactions in the synthesis of selenium donor containing schiff bases: applications of metal complexes in homogeneous catalysis, New Journal of Chemistry., 2023, 47,12511–12535.
CrossRef - Isloor A. M.; KallurayaB; Shetty P.,European Journal of Medicinal Chemistry.,2009,44, 3784- 3787.
CrossRef - Obaleye J. A.; Akinreme C. A.; Balogun E. A.; Adebayo J. O., Toxicological studies and antimicrobial properties of some Iron (III) complexes of African Journal of Biotechnology., 2007,6:2826–2832.
CrossRef - Abd E. W.; El, S., Derivatives of phosphate Schiff based transition metal complexes: synthesis, studies and biological activity. SpectrochimicaActa., 2004, 60(1-2), 271–277.
CrossRef - Shiu K. B.; Liu S. A.; Lee G. H., One-pot conditional self-assembly of multicoppermetallacycles, Inorganic Chemistry.,2010, 49(21), 9902–9908.
CrossRef - Yeşilel O. Z.; Erer H.; Kaştaş G.; Kani I. B., Hydrogen bonded networks and a self-assembled 1D water cluster in nickel(II) and copper(II)-orotate complexes, Polyhedron,2010, 29(13), 2600–2608.
CrossRef - Habib H. A.; Gil-Hernández B.; Abu-Shandi K.; Sanchiz J.; Janiak C., Iron, copper and zinc ammonium-1-hydroxyalkylidene-diphosphonates with zero-, one- and two-dimensional covalent metal-ligand structures extended into three-dimensional supramolecular networks by charge-assisted hydrogen-bonding, Polyhedron., 2010, 29(12), 2537–2545.
CrossRef - Al-Jeboori M. J.; Al-Shihri A. S., An unusual coordination of potentially binucleating N2O Schiff base ligands with rhenium, Journal of Saudi Chemical Society.,2001, 5(3), 341-343.
- Al-Jeboori M. J.; Kashta A. A., Oxo-rhenium(V) complexes with tridentate Schiff base ligands, Mu’Tahlil-BuhuthWadirasat., 2004,19, 89-100.
- Costamagna J.; Ferraudi G.;Matsuhiro B.; Complexes of macrocycles with pendant arms as models for biological molecules, Coordination Chemistry Reviews., 2000, 196, 125–164.
CrossRef - Coughlin P. K.; Lippard, S. J.; Copper(II) chemistry in hexaazabinucleating macrocycles: hydroxide and acetate derivatives, Journal of the American Chemical Society., 1984,106(8), 2328–2336.
CrossRef - Januszko A.; Kaszynski P.; Grüner B., Liquid crystalline derivatives of bis(tricarbollide)Fe(II), Inorganic Chemistry., 2007, 46(15), 6078–6082.
CrossRef - Mone N., Nishigandha.; Shital H.; SunitaSalunkeG.; Surekha S.; Archana P.; Vivek M.; Mahesh J.; Ray J. B., Metal complexes of ‘Heena’ (2-hydroxy-1,4-naphthoquinone): Synthesis, Characterization and anticancer activity, , 2023, 546, 121290.
CrossRef - Ali M.A.; Musthafa SA.; Munuswamy-Ramanujam G.; Jaisankar V.; 3-Formylindole-based chitosan Schiff base polymer: Antioxidant and in vitro cytotoxicity studies on THP-1 cells. Carbohydrate Polymers., 2022, 290, 119501.
CrossRef - Sreenu D.;Aveli R.; Nirmala G.; Gali R.; Anantha Lakshmi P.V.; Shivaraj., Spectroscopic, quantum chemical calculations, antioxidant, anticancer, antimicrobial, DNA binding and photo physical properties of bioactive Cu(II) complexes obtained from trifluoromethoxy aniline Schiff bases, Journal of Molecular Structure. ,2022, 1249,131601.
CrossRef - Moamen S. Refat.; Hosam A Saad.; Adil A. Gobouri.; Mohammed Alsawat.; Abdel Majid A. Adam.; Samy M. El-Megharbel., Charge transfer complexation between some transition metal ions with azo Schiff base donor as a smart precursor for synthesis of nano oxides: An adsorption efficiency for treatment of Congo red dye in waste water, Journal of Molecular Liquids., 2022, 345,117140.
CrossRef - Hasibul Islam, Md.; Md. Abdul Hannan., ‘Schiff Bases: Contemporary Synthesis, Properties, and Applications’. Novelties in Schiff Bases. IntechOpen. 2024, doi:10.5772/intechopen.114850.
CrossRef - Ramhari M.; Kumari P.; Sharma A.; Fahmi N.; Nighat. Schiff Bases and Their Metal Complexes: Synthesis, Structural Characteristics and Applications.,2023, 5772/intechopen.108396.
- Claudel, M., Schwarte, J.V., Fromm, K.M., New Antimicrobial Strategies Based on Metal Complexes. Chemistry. 2020, 2, 849–899.
CrossRef - Abu-Yamin A.A., Abduh M.S., Saghir S.A.M., Al-Gabri, N., Synthesis, Characterization and Biological Activities of New Schiff Base Compound and Its Lanthanide Complexes. Pharmaceuticals. 2022, 15, 454. https://doi.org/10.3390/ph15040454
CrossRef
Accepted on: 05 May 2025
Second Review by: Dr. Naveen Rawat
Final Approval by: Dr. Ioana Stanciu










